Press Releases :: CohBar, Inc. (CWBR)

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay

Mar 26, 2018 9:00am EDT

CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes

Mar 19, 2018 4:35pm EDT

CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018

Dec 13, 2017 12:53pm EST

CohBar Announces Approval for Listing on the NASDAQ Capital Market

Dec 07, 2017 9:00am EST

CohBar Announces the Appointment of Dr. John Amatruda to its Board

Nov 13, 2017 4:03pm EST

CohBar, Inc. Announces Third Quarter 2017 Financial Results

Oct 26, 2017 9:00am EDT

CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

Oct 23, 2017 9:00am EDT

CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver Meeting® 2017

Oct 04, 2017 9:00am EDT

CohBar, Inc. Announces Scientific Presentation of CB4209/CB4211 Program for NASH at The AASLD Liver Meeting® 2017

Sep 08, 2017 9:00am EDT

CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017

Aug 14, 2017 4:05pm EDT

CohBar, Inc. Announces Second Quarter 2017 Financial Results